Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 7
1952 7
1953 11
1954 9
1955 3
1956 6
1957 6
1958 5
1959 4
1960 4
1961 2
1962 1
1963 1
1964 3
1993 1
1995 1
1996 1
1997 1
1999 2
2000 2
2001 6
2002 1
2013 1
2015 1
2016 2
2017 5
2018 5
2019 4
2020 13
2021 14
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

132 results
Results by year
Filters applied: . Clear all
Page 1
Anti-HBV specific beta-L-2'-deoxynucleosides.
Bryant ML, Bridges EG, Placidi L, Faraj A, Loi AG, Pierra C, Dukhan D, Gosselin G, Imbach JL, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Cretton-Scott E, Schinazi RF, Sommadossi JP. Bryant ML, et al. Among authors: placidi l. Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):597-607. doi: 10.1081/NCN-100002336. Nucleosides Nucleotides Nucleic Acids. 2001. PMID: 11563077 Review.
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L, Faraj A, Loi AG, Pierra C, Egron D, Cretton-Scott E, Gosseli G, Périgaud C, Martin LT, Schinazi RF, Imbach JL, el Kouni MH, Bryant ML, Sommadossi JP. Placidi L, et al. Antivir Chem Chemother. 2001 Mar;12(2):99-108. doi: 10.1177/095632020101200203. Antivir Chem Chemother. 2001. PMID: 11527047 Free article.
A Multicentre Evaluation of Dosiomics Features Reproducibility, Stability and Sensitivity.
Placidi L, Gioscio E, Garibaldi C, Rancati T, Fanizzi A, Maestri D, Massafra R, Menghi E, Mirandola A, Reggiori G, Sghedoni R, Tamborra P, Comi S, Lenkowicz J, Boldrini L, Avanzo M. Placidi L, et al. Cancers (Basel). 2021 Jul 30;13(15):3835. doi: 10.3390/cancers13153835. Cancers (Basel). 2021. PMID: 34359737 Free PMC article.
Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus.
Hernandez-Santiago B, Placidi L, Cretton-Scott E, Faraj A, Bridges EG, Bryant ML, Rodriguez-Orengo J, Imbach JL, Gosselin G, Pierra C, Dukhan D, Sommadossi JP. Hernandez-Santiago B, et al. Among authors: placidi l. Antimicrob Agents Chemother. 2002 Jun;46(6):1728-33. doi: 10.1128/AAC.46.6.1728-1733.2002. Antimicrob Agents Chemother. 2002. PMID: 12019082 Free PMC article.
Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives.
Cusumano D, Boldrini L, Dhont J, Fiorino C, Green O, Güngör G, Jornet N, Klüter S, Landry G, Mattiucci GC, Placidi L, Reynaert N, Ruggieri R, Tanadini-Lang S, Thorwarth D, Yadav P, Yang Y, Valentini V, Verellen D, Indovina L. Cusumano D, et al. Among authors: placidi l. Phys Med. 2021 May;85:175-191. doi: 10.1016/j.ejmp.2021.05.010. Epub 2021 May 19. Phys Med. 2021. PMID: 34022660 Review.
What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans.
Hernandez V, Hansen CR, Widesott L, Bäck A, Canters R, Fusella M, Götstedt J, Jurado-Bruggeman D, Mukumoto N, Kaplan LP, Koniarová I, Piotrowski T, Placidi L, Vaniqui A, Jornet N. Hernandez V, et al. Among authors: placidi l. Radiother Oncol. 2020 Dec;153:26-33. doi: 10.1016/j.radonc.2020.09.038. Epub 2020 Sep 25. Radiother Oncol. 2020. PMID: 32987045 Free article. Review.
132 results